Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers December 18, 2018
Pharmacy Choice - News - Front Page Healthcare News - December 18, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/18/18 - 38 Patient Groups Speak Out Against Recent Ruling in Texas V. U.S.
The American Diabetes Association issued the following joint statement with 37 other organizations:. U.S., which found all of the Affordable Care Act to be unconstitutional, 38 patient groups issued the following statement:. "In eliminating the ACA penalty for individuals who are not insured, Congress did not intend that individuals could once aga
12/18/18 - AbbVie licences BioArctics Parkinsons disease portfolio [Syrian Arab News Agency]
Swedish biopharma company BioArctic has secured clearance from US Federal Trade Commission to out-licence its alpha-synuclein antibody portfolio to AbbVie. AbbVie decided to licence the therapeutics under an option that is part of the research, development, option and license agreement signed with BioArctic in September 2016. Under the partnership,
12/18/18 - ACA Repeal Bills Would Do Much the Same Damage as Judge's Decision to Strike Down the Law
President Trump and some congressional Republicans are portraying federal Judge Reed O'Connor's ruling striking down the Affordable Care Act as an opportunity to return to last year's ACA "repeal and replace" proposals, which they argue could solve the problems the ruling would create if allowed to stand. Fortunately, Judge O'Connor's ruling does n
12/18/18 - Anaesthesia And Respiratory Devices Market to reach USD 33.11 billion by 2023 - Market Data Forecast
Anaesthesia And Respiratory Devices Market By Device, Respiratory Devices And By Region- Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts. Anaesthesia and Respiratory Devices Market Overview. Anesthetic devices supply an accurate and continuous supply of medical gases associated with a precise concentration of anesthetic vapor a
12/18/18 - Are Fitbits the Answer to Nurse Fatigue?
The University of Wisconsin Madison campus issued the following news:. Activity trackers might lead to better outcomes for hospital patients when nurses wear them. Now a UW-Madison School of Nursing professor is taking them a step further by using them to track nurse movement in hospitals.
12/18/18 - Artificial Intelligence Is Propelling the Pharmaceutical Industry By Enabling Smart Drug Discovery Solutions
Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:. "Pharmaceutical companies are increasingly recognizing the value of deploying Artificial Intelligence- based platforms that can leverage data regarding gene...
12/18/18 - Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial
On December 17 Asarina Pharma's Scientific Advisory Board gave its full backing to the company's upcoming trial of a new preventive treatment for Menstrual Migraine. Sepranolone, the new therapy from Asarina Pharma, aims to prevent Menstrual Migraine from occurring. Asarina Pharma's SAB has now given its input and full backing on the proposed proto
12/18/18 - Astellas buys Potenza Therapeutics for up to $405m [Tehran Times (Iran)]
Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405 m. Astellas made an upfront payment of $164.6 m; Potenza will be eligible for additional payment of up to $240.1 m dependent on the progress of different programmes in clinical development. Following the completion of t
12/18/18 - BeiGene Initiates Two Global Phase 3 Front-Line Clinical Trials of Tislelizumab, in Patients with Gastric Cancer and in Patients with Esophageal Cancer [T-break Tech (Middle East)]
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the first patients have been enrolled in two global Phase 3 clinical trials of its investigational anti-PD-1 antibody, tislelizumab.
12/18/18 - Boehringer Ingelheim Launches a Tool to Aid in the Prevention of African Swine Fever
INGELHEIM AM RHEIN, Germany, Dec. 17 Boehringer Ingelheim, a pharmaceutical company, issued the following news release:. -Boehringer Ingelheim reconfirms its commitment to developing new innovative solutions to address current challenges. Boehringer Ingelheim has developed ASF COMBAT.
CLEARWATER, FL Bovie Medical Corporation, a maker of medical devices and supplies and the developer of J-Plasma , a patented surgical product marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market, today announced the appointment of Tara H. Semb as Chief Financial Officer, effective January 2, 2019.
12/18/18 - Bridge Biotherapeutics Announces FDA Clearance of IND for its BBT-877, an Autotaxin Inhibitor for IPF [Sport360]
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@ TMC in Houston, Texas, announced that the Investigational New Drug application for BBT-877, a potent best-in-class drug candidate for Idiopathic Pulmonary Fibrosis, has been cleared by the US Food and Drug Administrati
12/18/18 - Celltrion/Tevas Herceptin biosimilar approved in US [Syrian Arab News Agency]
The FDA has approved Celltrion and Tevas biosimilar of Roches breast cancer drug Herceptin, the second potential competitor to the cancer blockbuster in the US. All three are threatened by biosimilar competition, although Mylan and Celltrion will be unable to launch Herceptin in the US until the patent expires. Celltrion and Teva began an exclusive
12/18/18 - Curetis Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform Collaboration leverages Ares Genetics antibiotic resistance database ARESdb Short-term focus on repurposing existing antibiotics to treat infections with multi drug resistant pathogens Vienna, Austria, Holzgerlingen, Germany and Amsterdam, The...
12/18/18 - DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy
Under the terms of the agreement, Innovare will use DelSiTech's technology on its peptide membrane fusion inhibitor, targeting the envelope protein of human immunodeficiency virus-1. "This agreement with Innovare follows an already successful and long-lasting collaboration on this peptide", said Dr. "Using DelSiTech's platform, we have developed
12/18/18 - Donald Trump calls on Congress to find bipartisan replacement for Obamacare
We have a chance, working with the Democrats, to deliver great HealthCare! A confirming Supreme Court Decision will lead to GREAT HealthCare results for Americans! The ruling is expected to spark a heated fight in the court system and on Capitol Hill, where Democrats who rally for the Affordable Care Act, also known as Obamacare, and Medicare for A
12/18/18 - EhmetDx gets FDA nod for X-Ray 3D CBCT positioning software [Kuwait News Agency]
Medical device firm EhmetDx has secured 510 clearance from the US Food and Drug Administration for its X-Ray 3 D CBCT positioning software. PhotoElectron is currently PhotoElectron, while Still River Systems is Mevion Medical Systems). Based in Plymouth of Michigan, EhmetDx is formed by a consortium of healthcare-focused engineers, scientists and..
12/18/18 - ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease [Sport360]
ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that the U.S. Food and Drug Administration has granted the ExCellTheras lead solution, ECT-001, orphan drug designation for the prevention of graft-versus-host-disease.
12/18/18 - Federal judge in Texas rules Affordable Care Act unconstitutional
A federal judge in Texas threw a dagger into the Affordable Care Act on Friday night, ruling that the entire health care law is unconstitutional because of a recent change in federal tax law. the president wrote just after 9 p.m. "Now Congress must pass a STRONG law that provides GREAT healthcare and protects pre-existing conditions. For their part
12/18/18 - Federal Register Extracts
Agency: " Food and Drug Administration, HHS." SUMMARY: The Food and Drug Administration is announcing our intent to consider the appropriate classification of hyaluronic acid intra-articular products intended for the treatment of pain in osteoarthritis of the knee. FOR FURTHER INFORMATION CONTACT: Leigh Hayes, Office of Combination Products, Food a
12/18/18 - GC Pharma wins nod to carry out clinical trials on hemophilia drug [T-break Tech (Middle East)]
GC Pharma announced on Dec. 17 it has won approval from the local public health authority to carry out clinical tests on a drug that can be used to treat hemophilia. The drug company, also known as Green Cross, said the Ministry of Food and Drug Safety has granted approval for testing of the MG1113 on people. It marks the first time for a locally m
Glenmark Pharmaceuticals has got approval from the US Food and Drug Administration to launch its generic version of hydrocortisone valerate ointment USP, 0.2%, which is indicated for the treatment of a variety of skin conditions.
12/18/18 - Global Disposable Medical Gloves Market Insight Report Study on Volume , Revenue, Share and Size in-Depth 2017-2026
New York, NY 12/17/2018 A report on Disposable Medical Gloves begins with a deep introduction of the global Disposable Medical Gloves market and then delves broad into specific segments such as type, material, application, end user, and region, policy study, Disposable Medical Gloves value chain structure, and upcoming trends in particular se
12/18/18 - Global Endoscope Reprocessing Device Market Worth US$ 10,323.1 Mn by 2027: Increasing demand for advanced healthcare services, increase in purchasing power, lower pricing in the region and green field opportunities for the development of medical infr
Valley Cottage, NY 12/17/2018 Future Market Insights delivers key insights and presents a revised forecast of the global vital signs monitoring devices market for a 10 year period from 2017 to 2027 in an upcoming report titled "Vital Signs Monitoring Devices Market: Global Industry Analysis and Opportunity Assessment 2017 2027." The global
12/18/18 - Global Personalized Medicine Market Set for Rapid Growth to Reach Around $3466 Mn by 2024: Global personalized medicine market expected to generate revenue of around USD 3466 million by 2024, growing at a CAGR of around 11.9% between 2018 and 2024. P
Sarasota, FL 12/18/2018 Zion Market Research has published a new report titled "Personalized Medicine Market by Therapeutic Area, by Application, by End-User, and by Technology: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 2024". According to the report, the global personalized medicine market was valued at appro
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement